IBANGS Annual Meeting 2026:
Genes, Brain and Behavior
June 8-11, 2026
University of Pittsburgh, Pittsburgh, PA, USA
Conference Agenda
Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).
|
Daily Overview |
| Session | |
|
Symposium 5: Bridging the Rodent to HumanTranlational Gap: Marmosets as Model Systems for the Study of Alzheimer's Disease Location: Assembly Room/Ballroom Session Chair: Lauren Bailey Session Chair: Stacey Rizzo | |
| Presentation 3 | |
From Marmosets to Man: Building a Translational Platform to Advance Alzheimer's Disease Research University of Pittsburgh School of Medicine Thais Rafael Guimarães1, Jung Eun Park1, Catrina Spruce2, Stephanie Hachem1, Swati Banerjee1, Lauren K Hayrynen Schaeffer1, Gregg E Homanics1, Stacey J Sukoff Rizzo1, Gregory W Carter,2, Afonso C Silva1, and Amantha Thathiah1 Progress in preclinical Alzheimer’s disease (AD) research has been constrained by models that fail to faithfully recapitulate human aging and overt AD neuropathology. The common marmoset (Callithrix jacchus), a New World non-human primate, exhibits aging trajectories, genetic heterogeneity, and complex social behaviors closely resembling those of humans, providing a highly translational platform for age-related neurodegenerative research. Importantly, marmoset studies uniquely enable longitudinal correlation of in vitro cellular models with in vivo assessments across the marmoset lifespan. We performed an integrated ex vivo and in vitro characterization of marmoset AD and tauopathy models. Immunohistochemical analyses of postmortem brains revealed robust amyloid-β (Aβ) and tau pathology, along with the associated cellular pathology. To establish an in vitro cellular system, we adapted a well-established human direct reprogramming protocol to generate age-conserved induced neurons (iNs) from marmoset fibroblasts. Comparative, unbiased RNA-seq analyses of marmoset and human iN conversion trajectories revealed significant species-specific differences, guiding targeted optimization of the reprogramming strategy. The refined protocol achieved high-efficiency neuronal conversion, improved cell survival and maturation, and preserved AD-relevant protein expression, including amyloid precursor protein (APP)/Aβ and tau. Together, this integrated framework establishes the marmoset as a powerful translational model for AD research. This platform enables minimally invasive mechanistic studies, longitudinal analyses, high-throughput drug screening, and therapeutic discovery aimed at accelerating disease-modifying strategies for AD. 1University of Pittsburgh School of Medicine, Pittsburgh, PA, USA 2The Jackson Laboratory, Bar Harbor, ME, USA | |

